Trial Profile
A Phase 1b Dose-escalating Study With RBT-1, in Healthy Volunteers and Subjects With Chronic Kidney Disease Stage 3b-4
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Iron-sucrose/tin-protoporphyrin (Primary)
- Indications Renal failure
- Focus Biomarker; Pharmacodynamics
- Sponsors Renibus Therapeutics
- 22 Aug 2019 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 22 Aug 2018 New trial record